El-Masry, T.A.; El-Nagar, M.M.F.; El Mahdy, N.A.; Alherz, F.A.; Taher, R.; Osman, E.Y.
Potential Antitumor Activity of Combined Lycopene and Sorafenib against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals 2024, 17, 527.
https://doi.org/10.3390/ph17040527
AMA Style
El-Masry TA, El-Nagar MMF, El Mahdy NA, Alherz FA, Taher R, Osman EY.
Potential Antitumor Activity of Combined Lycopene and Sorafenib against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals. 2024; 17(4):527.
https://doi.org/10.3390/ph17040527
Chicago/Turabian Style
El-Masry, Thanaa A., Maysa M. F. El-Nagar, Nageh A. El Mahdy, Fatemah A. Alherz, Reham Taher, and Enass Y. Osman.
2024. "Potential Antitumor Activity of Combined Lycopene and Sorafenib against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation" Pharmaceuticals 17, no. 4: 527.
https://doi.org/10.3390/ph17040527
APA Style
El-Masry, T. A., El-Nagar, M. M. F., El Mahdy, N. A., Alherz, F. A., Taher, R., & Osman, E. Y.
(2024). Potential Antitumor Activity of Combined Lycopene and Sorafenib against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals, 17(4), 527.
https://doi.org/10.3390/ph17040527
